Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published October 6, 1995 | public
Journal Article

Myt1: A Membrane-Associated Inhibitory Kinase That Phosphorylates Cdc2 on Both Threonine-14 and Tyrosine-15

Abstract

Cdc2 is the cyclin-dependent kinase that controls entry of cells into mitosis. Phosphorylation of Cdc2 on threonine-14 and tyrosine-15 inhibits the activity of the enzyme and prevents premature initiation of mitosis. Although Wee1 has been identified as the kinase that phosphorylates tyrosine-15 in various organisms, the threonine-14-specific kinase has not been isolated. A complementary DNA was cloned from Xenopus that encodes Myt1, a member of the Wee1 family that was discovered to phosphorylate Cdc2 efficiently on both threonine-14 and tyrosine-15. Myt1 is a membrane-associated protein that contains a putative transmembrane segment. Immunodepletion studies suggested that Myt1 is the predominant threonine-14-specific kinase in Xenopus egg extracts. Myt1 activity is highly regulated during the cell cycle, suggesting that this relative of Wee1 plays a role in mitotic control.

Additional Information

© 1995 American Association for the Advancement of Science. Received 29 June 1995; accepted 6 September 1995. We are grateful to D. Morgan (University of California, San Francisco) for supplying the baculovirus transfer vector, M. Solomon (Yale University) for providing Cdc2 mutant plasmids. J. Kuang (M. D. Anderson Cancer Center) for supplying MPM-2 antibodies, and B. Wold and members of the W.G.D. group for critical reading of this manuscript . Supported by grants from NIH, Lucille P. Markey Charitable Trust, and NSF. P.R.M. and T.R.C. were supported by fellowships from the Helen Hay Whitney Foundat ion and NIH (National Research Service Awards), respectively. P.R.M. is an associate and W.G.D. is an investigator at the Howard Hughes Medical Institute.

Additional details

Created:
August 20, 2023
Modified:
October 18, 2023